In the life sciences industry, one of the biggest hurdles for research teams is the literature review process.
Every new clinical study, drug discovery effort, or regulatory submission requires researchers to review hundreds of scientific papers, journals, and reports.
Traditionally, this was done manually by experts who had to read, extract, and summarize findings. While thorough, this approach came with serious challenges:
- Time-Consuming – Reviews often stretched over several months.
- Prone to Human Error – Important details could be overlooked.
- Slowed Innovation – Lengthy review timelines delayed research progress and decision-making.
This bottleneck meant that valuable insights were often delayed, directly impacting both healthcare providers and patients waiting for new treatments.
